Vincenzo Salemme

University of Turin — Italy

Medicine · Health Sciences

10h-index581citations24works0.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Cells and Metastasis(4), Immune cells in cancer(4), Neuroblastoma Research and Treatments(4), Cancer, Hypoxia, and Metabolism(3), Cell Adhesion Molecules Research(3)

Publications24 total

IL-3/STAT5/miR-155-5p axis supports stem-related pathway reprogramming in TNBC
Breast Cancer Research·2025· 1 citedOpen Access
The adaptor protein SKT interacts with PSD-95 and SHANK3 and affects synaptic functions
Cell Reports·2025· 1 citedOpen Access
A breast cancer <scp>PDX</scp> collection enriched in luminal (<scp>ER</scp><sup>+</sup>) tumors and young premenopausal patients to identify new therapeutic strategies for high‐risk patients<sup>†</sup>
The Journal of Pathology·2025· 1 citedOpen Access
Current Applications of Endothelial Progenitor Cells–Derived Extracellular Vesicles: From Vascular Repair to Sepsis
Stem cells in clinical applications·2025
p140Cap modulates Wnt/ß-catenin signaling by regulating Dishevelled and Axin1/Axin2 destruction complex dynamic in Breast cancer
Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B))·2025
p140Cap regulation of Wnt β-catenin signaling pathway: molecular mechanisms
Digital Access to Libraries·2024
p140Cap-mediated reduction of stem cells enhances breast cancer chemosensitivity by modulating ABCC1 transporter
Digital Access to Libraries·2024
p140Cap modulates the mevalonate pathway decreasing cell migration and enhancing drug sensitivity in breast cancer cells
Cell Death and Disease·2023· 11 citedOpen Access
The role of tumor microenvironment in drug resistance: emerging technologies to unravel breast cancer heterogeneity
Frontiers in Oncology·2023· 76 citedOpen Access
p140Cap inhibits β-Catenin in the breast cancer stem cell compartment instructing a protective anti-tumor immune response
Nature Communications·2023· 13 citedOpen Access
p140Cap Regulates the Composition and Localization of the NMDAR Complex in Synaptic Lipid Rafts
Journal of Neuroscience·2022· 8 citedOpen Access
Cholesterol and Its Derivatives: Multifaceted Players in Breast Cancer Progression
Frontiers in Oncology·2022· 36 citedOpen Access
STAT3 induces breast cancer growth via ANGPTL4, MMP13 and STC1 secretion by cancer associated fibroblasts
Oncogene·2022· 112 citedOpen Access
p130Cas/BCAR1 and p140Cap/SRCIN1 Adaptors: The Yin Yang in Breast Cancer?
Frontiers in Cell and Developmental Biology·2021· 10 citedOpen Access
The Scaffold Protein p140Cap as a Molecular Hub for Limiting Cancer Progression: A New Paradigm in Neuroblastoma
IntechOpen eBooks·2021Open Access
The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy
Frontiers in Oncology·2021· 234 citedOpen Access
The N-terminal domain of the adaptor protein p140Cap interacts with Tiam1 and controls Tiam1/Rac1 axis.
PubMed Central·2020· 7 citedOpen Access
The p140Cap adaptor protein as a molecular hub to block cancer aggressiveness
Cellular and Molecular Life Sciences·2020· 10 citedOpen Access
Dissecting the Shared and Context-Dependent Pathways Mediated by the p140Cap Adaptor Protein in Cancer and in Neurons
Frontiers in Cell and Developmental Biology·2019· 9 citedOpen Access
Correction to: The SRCIN1/p140Cap adaptor protein negatively regulates the aggressiveness of neuroblastoma
Cell Death and Differentiation·2019· 4 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Giorgia Centonze(17), Paola Defilippi(16), Emilia Turco(16), Alessandro Morellato(11), Dora Natalini(10), Costanza Angelini(9), Jennifer Chapelle(8), Francesca Nigrelli(6), Valeria Poli(5), Daniela Taverna(5), Silvia Grasso(5), Alessia Lamolinara(5), Sara Cabodi(5), Manuela Iezzi(5), Federica Cavallo(4), Alessio Piccolantonio(4), Pietro Arina(4), Chiara Riganti(4), Daniela Tosoni(4), Matteo Poncina(4)